FMISO-PET and immunohistochemistry verified tumor oxygenation, stemness, and immunosupportive microenvironment after preoperative neoadjuvant bevacizumab for newly diagnosed glioblastoma.
暂无分享,去创建一个
K. Miyake | Yohei Yamamoto | D. Ogawa | Y. Murayama | Kenta Suzuki | Masayuki Shimoda | Y. Akasaki | Jun Takei | Toshihide Tanaka | Tomoya Suzuki | N. Fukasawa